Literature DB >> 23725504

Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Edlira Pajenga1, Tefta Rexha, Silva Çeliku, Gazmend Bejtja, Mimoza Pisha.   

Abstract

The role of reproductive factors in the aetiology of ovarian cancer had been evaluated in hospital-based case-control study conducted in Albania, providing a total dataset of 283 cases and 1019 controls. Logistic regression models were used to obtain relative risk (OR) estimates. The present results showed that parity had protective effects which increased until the forth birth and the trend in risk was significant (p < 0.01). In each stratum and overall, nulliparous women appeared to be at highly increased risk compared to those who had different number of births (OR=12.5, 95%, CI: 2.4-63.8). Evaluation of early age at menarche and late age at menopause, showed statistically significant increased risk. Furthermore, increased risk was observed between pre-menopausal women and never-married nulliparity women, respectively (OR=1.44 95%, CI: 0.88-2.36; OR=8.98, 95%, CI: 1.44 - 56.14), but ovarian cancer risk was reduced for hysterectomized women. These findings suggest that Albanian women have risk factors similar to women in western countries.
© 2013 Association of Basic Medical Sciences of FB&H. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23725504      PMCID: PMC4333939          DOI: 10.17305/bjbms.2013.2371

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  30 in total

Review 1.  Age at natural menopause and the risk of epithelial ovarian cancer.

Authors:  J M Schildkraut; G S Cooper; S Halabi; B Calingaert; P Hartge; A S Whittemore
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

2.  Timing of pregnancy and the risk of epithelial ovarian cancer.

Authors:  David C Whiteman; Victor Siskind; David M Purdie; Adèle C Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254

3.  The woman at risk for developing ovarian cancer.

Authors:  L McGowan; L Parent; W Lednar; H J Norris
Journal:  Gynecol Oncol       Date:  1979-06       Impact factor: 5.482

4.  Endocrine characteristics of adolescent menstrual cycles: impact of early menarche.

Authors:  R Vihko; D Apter
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

5.  Factors affecting the association of oral contraceptives and ovarian cancer.

Authors:  D W Cramer; G B Hutchison; W R Welch; R E Scully; R C Knapp
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

6.  Reproductive and hormonal factors and ovarian cancer.

Authors:  F Chiaffarino; C Pelucchi; F Parazzini; E Negri; S Franceschi; R Talamini; E Conti; M Montella; C La Vecchia
Journal:  Ann Oncol       Date:  2001-03       Impact factor: 32.976

Review 7.  Ovarian carcinogenesis: an alternative hypothesis.

Authors:  Jurgen M J Piek; Paul J van Diest; René H M Verheijen
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  "Incessant ovulation" and ovarian cancer.

Authors:  J T Casagrande; E W Louie; M C Pike; S Roy; R K Ross; B E Henderson
Journal:  Lancet       Date:  1979-07-28       Impact factor: 79.321

9.  Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.

Authors:  Tomas Riman; Paul W Dickman; Staffan Nilsson; Nestor Correia; Hans Nordlinder; Cecilia M Magnusson; Ingemar R Persson
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

10.  Menstrual and reproductive factors in relation to ovarian cancer risk.

Authors:  L Titus-Ernstoff; K Perez; D W Cramer; B L Harlow; J A Baron; E R Greenberg
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

View more
  1 in total

1.  Potential risk factors of ovarian cancer and analysis of CA125, a biomarker used for its monitoring and diagnosis.

Authors:  Muhammad Mansha; Arooba Gill; Peter C Thomson
Journal:  Mol Biol Rep       Date:  2019-04-20       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.